Page last updated: 2024-08-22

butylhydroxybutylnitrosamine and Disease Models, Animal

butylhydroxybutylnitrosamine has been researched along with Disease Models, Animal in 41 studies

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-19907 (17.07)18.7374
1990's7 (17.07)18.2507
2000's8 (19.51)29.6817
2010's16 (39.02)24.3611
2020's3 (7.32)2.80

Authors

AuthorsStudies
Ando, R; Etani, T; Iida, K; Kato, H; Kawai, N; Nagai, T; Nagayasu, Y; Naiki, T; Naiki-Ito, A; Nozaki, S; Suzuki, S; Takahashi, S; Yasui, T1
Bonnal, JL; Mauroy, B; Philyppov, IB; Prevarskaya, N; Rock, A; Roudbaraki, M; Shuba, YM; Sotkis, GV1
Chourlia, A; Doroszko, M; Dragomir, A; Elgendy, R; Kerzeli, IK; Larsson, E; Lord, M; Malmstrom, PU; Mangsbo, SM; Nelander, S; Segersten, U; Stepanek, I; van Hooren, L1
Arantes-Rodrigues, R; Gil da Costa, RM; Oliveira, PA; Vasconcelos-Nóbrega, C1
Eriksson, P; Foth, M; Ismail, NFB; Iwata, T; Knowles, MA; Kung, JSC; Salmond, JM; Sansom, OJ; Sjödahl, G; Tomlinson, D1
Attalla, B; Bédard, A; Billger, M; Chang, J; Haile, S; Kirk, J; Söderberg, M1
Du, Z; Guo, H; Li, C; Wang, R; Xiong, W; Xue, J; Yu, M1
Chang, C; Chen, CC; Chuang, WM; Hsieh, TF; Hung, XF; Lin, MH; Ma, WL; Shyr, CR; Tsai, YR; Zhang, C; Zhang, Q1
DeGregorio, MW; Griffey, SM; Gutierrez, AM; Hanson, GK; Kao, CJ; Vang, DP; Wolf, M; Wurz, GT1
Beachy, PA; Honeycutt, JD; Hsieh, MH; Kawano, S; Lim, A; Odegaard, JI; Shin, K1
Huang, X; Xu, Q; Xu, Y; Yang, J; Zhang, G; Zhang, Z1
Dahm, HH; Lehnen-Holtum, V; Rübben, H1
Lee, JK; Theodorescu, D; Williams, PD1
Barbisan, LF; de Moura, NA; Grassi, TF; Rodrigues, MA1
Chyau, CC; Hsu, JD; Lee, HJ; Ou, TT; Wang, CJ; Wu, CH1
Cunha, FX; Figueiredo, A; Garrido, P; Mota, A; Neto, P; Nunes, S; Parada, B; Pinto, R; Reis, F; Rocha-Pereira, P; Rodrigues-Santos, P; Ruivo, J; Sereno, J; Teixeira, F; Teixeira-Lemos, E1
Fujii, N; Kobayashi, T; Kotani, H; Masutani, H; Matsui, Y; Nishiyama, H; Nishizawa, K; Ogawa, O; Oishi, S; Saito, R; Toda, Y; Yodoi, J1
Bae, SC; Kim, J; Kim, SK; Kim, WJ; Lee, OJ; Yun, SJ1
Izumi, K; Li, Y; Miyamoto, H1
Albuquerque, IL; Alves, MK; Castro, JD; de Almeida, PR; Dias, TA; Dornelas, CA; Faria, MH; Fechine-Jamacaru, FV; Lemos, TL; Magalhães, HI; Moraes, ME; Moraes, MO; Rabenhorst, SH1
Iseda, T; Takei, S; Yokoyama, M1
Matsushima, M; Sato, D1
Abdul-Ghani, R; Ariel, I; Ayesh, B; Ayesh, S; Birman, T; de Groot, N; Gofrit, O; Hochberg, A; Pizov, G; Schneider, T; Sidi, AA; Smith, Y1
Ayesh, S; Birman, T; Dinaburg, A; Gofrit, ON; Hochberg, A; Ohana, P1
Barbisan, LF; Bidinotto, LT; Rocha, NS; Salvadori, DM; Spinardi-Barbisan, AL1
Aota, Y; Kobayashi, O; Koshikawa, T; Mitsuta, H; Murase, T1
Becci, PJ; Brown, CC; Moon, RC; Sporn, MB; Strum, JM; Thompson, HJ1
Akagi, K; Hara, Y; Hirose, M; Hoshiya, T; Ito, N; Takahashi, S1
Akaza, H; Ami, Y; Ideyama, Y; Imada, S; Koiso, K; Takenaka, T1
Frolov, AG; Iogannsen, MG; Pliss, GB; Vlasov, NN1
Ariel, I; Ayesh, S; de Groot, N; Elkin, M; Hochberg, A; Schneider, T1
Sato, D1
Adamek, M; Gabius, HJ; Kunze, E; Schulz, H1
Grubbs, CJ; Hill, DL; Kelloff, GJ; Koki, AT; Leahy, KM; Lubet, RA; Masferrer, JL; Seibert, K; Steele, VE1
Fukushima, S; Hayashi, Y; Hosono, M; Makino, S; Mori, S; Murai, T; Ohara, T; Takeda, R; Takeuchi, Y1
Bach, PH1
Kobayashi, Y1
Babaya, K; Hirao, Y; Momose, H; Okajima, E; Ozono, S; Samma, S1
Fukushima, S1
Babaya, K; Hirao, Y; Okajima, E; Ozono, S; Sanma, S; Sasaki, K1
Chowaniec, J; Chrysostomou, E; Gwynne, J; Hicks, RM; Nandra, K; Pedrick, M; Tomlinson, CN; Turton, JA1

Reviews

3 review(s) available for butylhydroxybutylnitrosamine and Disease Models, Animal

ArticleYear
The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model.
    Methods in molecular biology (Clifton, N.J.), 2018, Volume: 1655

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Transformation, Neoplastic; Disease Models, Animal; FANFT; Humans; Mice; Mice, Transgenic; Urinary Bladder Neoplasms

2018
The role of the androgen receptor in the development and progression of bladder cancer.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:7

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Castration; Disease Models, Animal; Disease Progression; Evidence-Based Medicine; Female; Gene Expression Regulation, Neoplastic; Humans; Incidence; Male; Neoplasms, Hormone-Dependent; Receptors, Androgen; Risk Factors; Sex Factors; Signal Transduction; Urinary Bladder Neoplasms

2012
A molecular basis for target-cell toxicity and upper urothelial carcinoma in analgesic abusers and patients with Balkan endemic nephropathy.
    IARC scientific publications, 1991, Issue:115

    Topics: Analgesics; Animals; Balkan Nephropathy; Butylhydroxybutylnitrosamine; Carcinogenicity Tests; Carcinogens; Cocarcinogenesis; Disease Models, Animal; Epithelium; Europe; FANFT; Humans; Hyperplasia; Incidence; Kidney Neoplasms; Kidney Papillary Necrosis; Models, Biological; Mycotoxicosis; Ochratoxins; Precancerous Conditions; Rats; Rats, Inbred Strains; Rodentia; Smoking; Substance-Related Disorders; Ureteral Neoplasms

1991

Other Studies

38 other study(ies) available for butylhydroxybutylnitrosamine and Disease Models, Animal

ArticleYear
Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway.
    Cancer science, 2020, Volume: 111, Issue:4

    Topics: Animals; Apoptosis; Butylhydroxybutylnitrosamine; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Luteolin; Male; Mice; Proto-Oncogene Proteins c-akt; Rats; rho GTP-Binding Proteins; Signal Transduction; Thioredoxins; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2020
Alterations in detrusor contractility in rat model of bladder cancer.
    Scientific reports, 2020, 11-12, Volume: 10, Issue:1

    Topics: Animals; Butylhydroxybutylnitrosamine; Disease Models, Animal; Male; Muscle Contraction; Rats; Rats, Wistar; TRPV Cation Channels; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Incontinence

2020
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
    PloS one, 2021, Volume: 16, Issue:7

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Longitudinal Studies; Male; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Proteinuria; Proteomics; Sequence Analysis, RNA; Single-Cell Analysis; Urinary Bladder; Urinary Bladder Calculi; Urothelium

2021
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation.
    The Journal of pathology, 2018, Volume: 246, Issue:3

    Topics: Animals; Butylhydroxybutylnitrosamine; Cell Transformation, Neoplastic; Cholecystitis, Acute; Disease Models, Animal; Disease Progression; Female; Genetic Predisposition to Disease; Lymphocytes; Male; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neutrophil Infiltration; Neutrophils; Phenotype; Receptor, Fibroblast Growth Factor, Type 3; Time Factors; Tumor Microenvironment; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium

2018
A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
    Regulatory toxicology and pharmacology : RTP, 2019, Volume: 103

    Topics: Administration, Oral; Animals; Benzhydryl Compounds; Butylhydroxybutylnitrosamine; Disease Models, Animal; Dose-Response Relationship, Drug; Glucosides; Male; Rats; Rats, Sprague-Dawley; Urinary Bladder Neoplasms

2019
[Long-term anti-cancer implants inhibiting the activity of tumor growth in animal models].
    Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2013, Volume: 30, Issue:3

    Topics: Animals; Antineoplastic Agents; Butylhydroxybutylnitrosamine; Delayed-Action Preparations; Disease Models, Animal; Doxorubicin; Female; Implants, Experimental; Polyanhydrides; Rats; Rats, Sprague-Dawley; Urinary Bladder Neoplasms

2013
Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation.
    Oncology reports, 2013, Volume: 30, Issue:6

    Topics: Androgens; Animals; Butylhydroxybutylnitrosamine; Carcinogenesis; Castration; Disease Models, Animal; Disease Progression; Epidermal Growth Factor; ErbB Receptors; Humans; Male; Mice; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Quinazolines; Receptors, Androgen; Signal Transduction; Transcriptional Activation; Urinary Bladder Neoplasms

2013
Induction of invasive transitional cell bladder carcinoma in immune intact human MUC1 transgenic mice: a model for immunotherapy development.
    Journal of visualized experiments : JoVE, 2013, Oct-30, Issue:80

    Topics: Animals; Butylhydroxybutylnitrosamine; Cancer Vaccines; Carcinogens; Carcinoma, Transitional Cell; Cytokines; Disease Models, Animal; Female; Humans; Immunotherapy; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mucin-1; T-Lymphocytes, Cytotoxic; Urinary Bladder Neoplasms

2013
Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.
    Nature cell biology, 2014, Volume: 16, Issue:5

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma; Cell Lineage; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Genotype; Hedgehog Proteins; Humans; Male; Mice; Mice, Transgenic; Neoplasm Invasiveness; Neoplastic Stem Cells; Phenotype; Recombinant Fusion Proteins; Time Factors; Tumor Burden; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium

2014
The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:9

    Topics: Androgens; Animals; Apoptosis; Butylhydroxybutylnitrosamine; Cell Proliferation; Disease Models, Animal; Male; Mice; Orchiectomy; Receptors, Androgen; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms

2015
[Karyometry of BBN-induced precancerosis of the urothelium : An experimental analysis].
    Der Urologe. Ausg. A, 2016, Volume: 55, Issue:10

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Disease Models, Animal; Karyometry; Precancerous Conditions; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Urinary Bladder Neoplasms; Urothelium

2016
Molecular credentialing of rodent bladder carcinogenesis models.
    Neoplasia (New York, N.Y.), 2008, Volume: 10, Issue:8

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Disease Models, Animal; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Invasiveness; Oligonucleotide Array Sequence Analysis; Rats; Urinary Bladder Neoplasms

2008
Potential effects of the herbicide Diuron on mammary and urinary bladder two-stage carcinogenesis in a female Swiss mouse model.
    Archives of toxicology, 2010, Volume: 84, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Butylhydroxybutylnitrosamine; Carcinogens; Disease Models, Animal; Diuron; Dose-Response Relationship, Drug; Female; Herbicides; Immunohistochemistry; Mammary Glands, Animal; Mice; Random Allocation; Urinary Bladder Neoplasms

2010
Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo.
    Journal of ethnopharmacology, 2011, Apr-26, Volume: 135, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Butylhydroxybutylnitrosamine; Carcinoma; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 2; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Male; Paeonia; Phosphorylation; Phytotherapy; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Urinary Bladder Neoplasms; Urothelium

2011
Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.
    Mediators of inflammation, 2010, Volume: 2010

    Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Inflammation Mediators; Kidney; Liver; Male; Oxidation-Reduction; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Urinary Bladder Neoplasms

2010
Thioredoxin-interacting protein suppresses bladder carcinogenesis.
    Carcinogenesis, 2011, Volume: 32, Issue:10

    Topics: Aged; Animals; Blotting, Western; Butylhydroxybutylnitrosamine; Carrier Proteins; Chemokine CXCL12; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Staging; Prognosis; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Survival Rate; Thioredoxins; Urinary Bladder Neoplasms

2011
Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model.
    PloS one, 2011, Volume: 6, Issue:10

    Topics: Animals; Butylhydroxybutylnitrosamine; Disease Models, Animal; Female; Gene Expression Profiling; Genes, myc; Humans; Mice; Niacinamide; Reproducibility of Results; Species Specificity; Urinary Bladder Neoplasms

2011
Angiogenesis inhibition by green propolis and the angiogenic effect of L-lysine on bladder cancer in rats.
    Acta cirurgica brasileira, 2012, Volume: 27, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Butylhydroxybutylnitrosamine; Carcinoma; Disease Models, Animal; Female; Lysine; Neovascularization, Pathologic; Plant Extracts; Propolis; Rats; Rats, Wistar; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Water

2012
Inhibitory effect of clotrimazole on angiogenesis associated with bladder epithelium proliferation in rats.
    International journal of urology : official journal of the Japanese Urological Association, 2003, Volume: 10, Issue:2

    Topics: Animals; Base Sequence; Butylhydroxybutylnitrosamine; Cell Division; Clotrimazole; Disease Models, Animal; Endothelial Growth Factors; Epithelium; Female; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Lymphokines; Molecular Sequence Data; Neovascularization, Pathologic; Probability; Random Allocation; Rats; Rats, Wistar; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors

2003
Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves.
    International journal of urology : official journal of the Japanese Urological Association, 2003, Volume: 10, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Camellia sinensis; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Phytotherapy; Plant Leaves; Plant Preparations; Rats; Rats, Wistar; Tea; Treatment Outcome; Urinary Bladder Neoplasms

2003
Gene expression in the bladder carcinoma rat model.
    Molecular carcinogenesis, 2004, Volume: 41, Issue:2

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Disease Models, Animal; DNA, Complementary; Gene Expression; Gene Expression Profiling; Insulin-Like Growth Factor II; Male; Rats; Rats, Wistar; RNA, Long Noncoding; RNA, Untranslated; Time Factors; Up-Regulation; Urinary Bladder Neoplasms

2004
Chemically induced bladder cancer--a sonographic and morphologic description.
    Urology, 2006, Volume: 68, Issue:1

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Disease Models, Animal; Female; Rats; Rats, Wistar; Ultrasonography; Urinary Bladder; Urinary Bladder Neoplasms

2006
Effects of ginger (Zingiber officinale Roscoe) on DNA damage and development of urothelial tumors in a mouse bladder carcinogenesis model.
    Environmental and molecular mutagenesis, 2006, Volume: 47, Issue:8

    Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Disease Models, Animal; DNA Damage; Male; Methylnitrosourea; Mice; Neoplasm Invasiveness; Plant Extracts; Urinary Bladder Neoplasms; Urologic Neoplasms; Zingiber officinale

2006
[Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor].
    Hinyokika kiyo. Acta urologica Japonica, 1983, Volume: 29, Issue:3

    Topics: Animals; Butylhydroxybutylnitrosamine; Cell Transformation, Neoplastic; Disease Models, Animal; DNA, Neoplasm; Humans; Male; Nitrosamines; Papilloma; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms

1983
N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.
    Cancer research, 1981, Volume: 41, Issue:3

    Topics: Animals; Butylhydroxybutylnitrosamine; Disease Models, Animal; Male; Mice; Microscopy, Electron; Neoplasms, Experimental; Nitrosamines; Tretinoin; Urinary Bladder Neoplasms

1981
Effects of green tea catechins in a rat multi-organ carcinogenesis model.
    Carcinogenesis, 1993, Volume: 14, Issue:8

    Topics: 1,2-Dimethylhydrazine; Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Butylhydroxybutylnitrosamine; Carcinogenicity Tests; Catechin; Cocarcinogenesis; Colonic Neoplasms; Dimethylhydrazines; Disease Models, Animal; Intestinal Neoplasms; Intestine, Small; Kidney Neoplasms; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Models, Biological; Neoplasms, Experimental; Rats; Rats, Inbred F344

1993
Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats.
    European urology, 1997, Volume: 31, Issue:3

    Topics: Administration, Oral; Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma; Cholestenone 5 alpha-Reductase; Disease Models, Animal; Enzyme Inhibitors; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Immunohistochemistry; Leuprolide; Male; Mice; Mice, Inbred C3H; Oxidoreductases; Rats; Rats, Wistar; Urinary Bladder Neoplasms

1997
[A model of rat's urinary bladder tumor induced by subcutaneous injection of N-butyl-N-(4-hydroxybutyl)-nitrosamine].
    Voprosy onkologii, 1998, Volume: 44, Issue:4

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma in Situ; Carcinoma, Transitional Cell; Disease Models, Animal; Glucuronidase; Papilloma; Rats; Urinary Bladder Neoplasms

1998
The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Carcinogenesis, 1998, Volume: 19, Issue:12

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Transformation, Neoplastic; Disease Models, Animal; Disease Progression; Epithelial Cells; Female; Gene Expression; Genomic Imprinting; In Situ Hybridization; Mice; Mice, Inbred C3H; Muscle Proteins; Precancerous Conditions; RNA, Long Noncoding; RNA, Untranslated; Urinary Bladder Neoplasms

1998
Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea.
    International journal of urology : official journal of the Japanese Urological Association, 1999, Volume: 6, Issue:2

    Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperplasia; Male; Papilloma; Rats; Rats, Wistar; Tea; Urinary Bladder Neoplasms

1999
Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response
    Journal of cancer research and clinical oncology, 2000, Volume: 126, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Disease Models, Animal; Drug Administration Schedule; Female; Galactosides; Immunity, Cellular; Immunohistochemistry; Incidence; Lectins; Mistletoe; Phytotherapy; Plant Lectins; Plant Preparations; Plant Proteins; Plants, Medicinal; Rats; Rats, Wistar; Ribosome Inactivating Proteins, Type 2; Specific Pathogen-Free Organisms; Toxins, Biological; Treatment Failure; Urinary Bladder Neoplasms

2000
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
    Cancer research, 2000, Oct-15, Volume: 60, Issue:20

    Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organ Specificity; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred F344; Sulfonamides; Urinary Bladder Neoplasms

2000
Renal pelvic carcinoma which shows metastatic potential to distant organs, induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
    Japanese journal of cancer research : Gann, 1991, Volume: 82, Issue:12

    Topics: Abdominal Neoplasms; Animals; Body Weight; Butylhydroxybutylnitrosamine; Disease Models, Animal; Hydronephrosis; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Urinary Bladder Neoplasms

1991
[Urinary bladder carcinogenicity of BBN in beige mice (Chediak-Higashi disease model)].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1989, Volume: 80, Issue:5

    Topics: Animals; Butylhydroxybutylnitrosamine; Chediak-Higashi Syndrome; Disease Models, Animal; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microscopy, Electron, Scanning; Nitrosamines; Urinary Bladder Neoplasms

1989
[Experimental model of urinary bladder tumor in rats for evaluation of chemotherapeutic agents].
    Hinyokika kiyo. Acta urologica Japonica, 1988, Volume: 34, Issue:11

    Topics: Animals; Antineoplastic Agents; Butylhydroxybutylnitrosamine; Disease Models, Animal; Drug Screening Assays, Antitumor; Male; Rats; Rats, Inbred F344; Rats, Inbred Strains; Urinary Bladder Neoplasms

1988
[Animal models of bladder cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1988, Volume: 34, Issue:11

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemical Phenomena; Chemistry; Disease Models, Animal; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Precancerous Conditions; Rats; Urinary Bladder Neoplasms

1988
Scanning electron microscopy of changes in the urinary bladder in dogs treated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
    Urological research, 1987, Volume: 15, Issue:1

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Disease Models, Animal; Dogs; Epithelium; Female; Hyperplasia; Nitrosamines; Urinary Bladder; Urinary Bladder Neoplasms

1987
Modulation of carcinogenesis in the urinary bladder by retinoids.
    Ciba Foundation symposium, 1985, Volume: 113

    Topics: Animals; Butylhydroxybutylnitrosamine; Cell Transformation, Neoplastic; Disease Models, Animal; Epithelium; Mice; Mice, Inbred Strains; Rats; Rats, Inbred F344; Retinoids; Time Factors; Urinary Bladder Neoplasms

1985